Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices
Eli Lilly and Novo Nordisk set to share obesity drug market, with sales expected to exceed $120 billion by 2030 - The Corner .eu
‘Thinness equals beauty’: Mounjaro misuse among women sparks health debate in Japan - The Japan Times
ADA26: Pfizer builds momentum for Metsera GLP-1 bet amid slew of Phase III starts this year - FirstWord Pharma